LYKA LABS
|
The Current P/S Ratio of LYKA LABS is 2.02.
| Share Price | ₹71.8 | Jul 09,2026 |
| Market Cap | ₹259.9 Cr | |
| Sales-TTM | ₹128.4 Cr | TTM-Consolidated Results |
| Price/Sales | 2.02x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹259.9 Cr] as on Jul 09,2026
(/) Sales [ ₹128.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.02x ]
Thus, for LYKA LABS , the investors are currently willing to pay '2.02 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !
The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LYKA LABS
PS Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.41x.
- LYKA LABS 's operated at median p/e ratio of 2.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2021 of 0.86x.
How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LYKA LABS | 128.4 | 2.02 | 259.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.96 | 465,195.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 17.12 | 180,823.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.85 | 165,725.0 |
| CIPLA LTD | 28,162.6 | 4.14 | 116,467.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.14 | 105,987.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.32 | 104,544.0 |
| LUPIN LTD | 27,958.0 | 4.09 | 114,441.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.26 | 115,695.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.71 | 91,283.7 |
| LAURUS LABS LTD | 6,812.9 | 11.92 | 81,210.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.02x |
| Max industry PS | 17.12x |
| Median industry PS | 4.26x |
| Average industry PS | 6.96x |
You may also like the below Video Courses